Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003541priorityCriticalpatent/ECSP003541A/es
Publication of ECSP003541ApublicationCriticalpatent/ECSP003541A/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La invención se refiere al uso de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención.
ECSP0035412000-06-232000-06-23COMBINACION DE INHIBIDORES DE MTP E INHIBIDORES DE HMG CoA REDUCTASA Y SU USO EN MEDICAMENTOS
ECSP003541A
(es)
formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase